Maxlinear Financials
Maxlinear (MXL) reported $467.6M in revenue for fiscal year 2025, up 29.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
MaxLinear is absorbing a smaller revenue base with a still-heavy engineering cost structure, not suffering a collapse in gross economics.
In FY2025, gross margin resilience at56.8% coexisted with a net loss of-$136.7M , indicating a fixed-cost absorption problem rather than weak gross economics. The swing back to free cash flow of$7.0M looks more like a working-capital release than an earnings recovery, because receivables and inventory both fell as revenue rebounded from FY2024.
Across FY2022 to FY2025, revenue more than halved from
Liquidity is still serviceable with a current ratio of 1.3x, but the cash buffer shrank from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Maxlinear's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Maxlinear, and counted as zero in the overall score.
Maxlinear scores 10.75, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.6B) relative to total liabilities ($344.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Maxlinear passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Maxlinear reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Maxlinear reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Maxlinear generated $467.6M in revenue in fiscal year 2025. This represents an increase of 29.7% from the prior year.
Maxlinear's EBITDA was -$82.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 51.0% from the prior year.
Maxlinear reported -$136.7M in net income in fiscal year 2025. This represents an increase of 44.3% from the prior year.
Maxlinear earned -$1.58 per diluted share (EPS) in fiscal year 2025. This represents an increase of 46.1% from the prior year.
Cash & Balance Sheet
Maxlinear generated $7.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 111.1% from the prior year.
Maxlinear held $72.8M in cash against $123.6M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Maxlinear's gross margin was 56.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.8 percentage points from the prior year.
Maxlinear's operating margin was -27.1% in fiscal year 2025, reflecting core business profitability. This is up 34.8 percentage points from the prior year.
Maxlinear's net profit margin was -29.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 38.8 percentage points from the prior year.
Maxlinear's ROE was -30.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 17.2 percentage points from the prior year.
Capital Allocation
Maxlinear invested $208.6M in research and development in fiscal year 2025. This represents a decrease of 7.4% from the prior year.
Maxlinear spent $20.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Maxlinear invested $12.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 28.7% from the prior year.
MXL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $568.9M | $467.6M+29.7% | $360.5M-48.0% | $693.3M-38.1% | $1.1B+25.5% | $892.4M+86.5% | $478.6M+50.9% | $317.2M-17.6% | $385.0M-8.4% | $420.3M+8.4% | $387.8M+29.1% | $300.4M+125.6% | $133.1M+11.3% | $119.6M+22.4% | $97.7M+35.9% | $71.9M |
| Cost of Revenue | $241.9M | $201.8M+21.8% | $165.7M-46.1% | $307.6M-34.6% | $470.5M+18.6% | $396.6M+49.2% | $265.8M+77.8% | $149.5M-15.2% | $176.2M-17.0% | $212.4M+34.5% | $157.8M+8.9% | $144.9M+183.3% | $51.2M+9.6% | $46.7M+25.9% | $37.1M+38.9% | $26.7M |
| Gross Profit | $327.0M | $265.8M+36.5% | $194.8M-49.5% | $385.7M-40.6% | $649.8M+31.0% | $495.8M+133.0% | $212.8M+26.9% | $167.7M-19.7% | $208.8M+0.4% | $208.0M-9.6% | $230.0M+48.0% | $155.4M+89.6% | $82.0M+12.3% | $73.0M+20.3% | $60.6M+34.0% | $45.2M |
| R&D Expenses | $215.1M | $208.6M-7.4% | $225.2M-16.4% | $269.5M-9.1% | $296.4M+6.5% | $278.4M+54.7% | $180.0M+83.0% | $98.3M-18.1% | $120.0M+6.9% | $112.3M+14.9% | $97.7M+14.4% | $85.4M+50.8% | $56.6M+6.6% | $53.1M+14.4% | $46.5M+15.7% | $40.2M |
| SG&A Expenses | $177.8M | $159.6M+15.4% | $138.3M+4.7% | $132.2M-21.3% | $168.0M+12.0% | $149.9M+15.3% | $130.0M+46.5% | $88.8M-12.8% | $101.8M-3.8% | $105.8M+64.2% | $64.5M-17.3% | $78.0M+128.1% | $34.2M+6.2% | $32.2M+18.1% | $27.3M+34.8% | $20.2M |
| Operating Income | -$77.6M | -$126.9M+43.2% | -$223.4M-484.4% | -$38.2M-121.2% | $180.2M+176.3% | $65.2M+164.5% | -$101.1M-358.5% | -$22.1M-15.5% | -$19.1M+11.9% | -$21.7M-134.4% | $63.1M+244.5% | -$43.6M-392.8% | -$8.9M+28.3% | -$12.3M+5.5% | -$13.1M+13.6% | -$15.1M |
| Interest Expense | $9.5M | $10.1M-7.5% | $10.9M+1.6% | $10.7M+9.6% | $9.8M-24.8% | $13.0M+0.3% | $13.0M+16.3% | $11.1M-21.9% | $14.3M+37.4% | $10.4M+9878.8% | $104K+4.0% | $100K+566.7% | $15K+275.0% | $4K-92.5% | $53K-23.2% | $69K |
| Income Tax | $17.4M | -$4.2M-165.0% | $6.5M-30.6% | $9.3M-81.0% | $49.2M+733.0% | $5.9M+136.3% | -$16.3M-29.2% | -$12.6M-89.2% | -$6.7M+73.2% | -$24.8M-1134.7% | $2.4M+517.0% | -$575K+66.3% | -$1.7M-523.9% | $402K+17.9% | $341K-95.1% | $7.0M |
| Net Income | -$103.8M | -$136.7M+44.3% | -$245.2M-235.2% | -$73.1M-158.5% | $125.0M+197.9% | $42.0M+142.6% | -$98.6M-395.5% | -$19.9M+24.1% | -$26.2M-185.2% | -$9.2M-115.0% | $61.3M+244.8% | -$42.3M-501.2% | -$7.0M+44.7% | -$12.7M+3.9% | -$13.3M+39.8% | -$22.0M |
| EPS (Diluted) | — | -$1.58+46.1% | -$2.93-222.0% | -$0.91-158.7% | $1.55+192.5% | $0.53+139.3% | -$1.35-382.1% | -$0.28+26.3% | -$0.38-171.4% | -$0.14-115.4% | $0.91+215.2% | -$0.79-315.8% | -$0.19+48.6% | -$0.37+7.5% | -$0.40+41.2% | -$0.68 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
MXL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $796.4M-7.9% | $864.6M-20.0% | $1.1B-8.5% | $1.2B+12.3% | $1.1B+2.7% | $1.0B+44.9% | $705.8M-5.1% | $743.6M-9.9% | $824.9M+95.2% | $422.7M+26.4% | $334.5M+146.5% | $135.7M+8.6% | $124.9M+13.0% | $110.6M-1.6% | $112.4M |
| Current Assets | $248.8M-23.1% | $323.4M-33.7% | $488.0M-13.3% | $563.1M+39.4% | $404.1M+11.7% | $361.7M+99.0% | $181.8M-1.9% | $185.4M-7.9% | $201.3M-5.4% | $212.8M+12.0% | $190.0M+88.3% | $100.9M+7.7% | $93.7M-4.4% | $98.0M+3.1% | $95.1M |
| Cash & Equivalents | $72.8M-38.6% | $118.6M-36.7% | $187.3M0.0% | $187.4M+43.5% | $130.6M-12.3% | $148.9M+60.6% | $92.7M+26.8% | $73.1M+1.8% | $71.9M-11.4% | $81.1M+19.3% | $68.0M+228.4% | $20.7M-21.8% | $26.4M+21.3% | $21.8M-22.2% | $28.0M |
| Inventory | $78.1M-13.5% | $90.3M-9.6% | $99.9M-37.8% | $160.5M+21.9% | $131.7M+34.6% | $97.8M+210.5% | $31.5M-24.5% | $41.7M-21.9% | $53.4M+101.0% | $26.6M-18.1% | $32.4M+198.8% | $10.9M+8.2% | $10.0M+1.4% | $9.9M+22.4% | $8.1M |
| Accounts Receivable | $46.1M-46.0% | $85.5M-49.9% | $170.6M-0.2% | $171.0M+42.8% | $119.7M+77.5% | $67.4M+33.8% | $50.4M-15.3% | $59.5M-10.0% | $66.1M+30.9% | $50.5M+19.1% | $42.4M+128.9% | $18.5M-7.7% | $20.1M+37.8% | $14.6M+39.7% | $10.4M |
| Goodwill | $318.6M0.0% | $318.6M0.0% | $318.6M+3.9% | $306.7M0.0% | $306.7M+1.3% | $302.8M+27.1% | $238.3M0.0% | $238.3M+0.1% | $238.0M+213.1% | $76.0M+52.7% | $49.8M+4044.8% | $1.2M | $0 | N/A | N/A |
| Total Liabilities | $344.5M-1.1% | $348.4M-11.6% | $394.0M-21.8% | $503.6M-10.3% | $561.2M-11.1% | $631.3M+117.0% | $290.9M-15.4% | $343.7M-21.4% | $437.4M+522.9% | $70.2M-1.9% | $71.6M+95.5% | $36.6M-4.3% | $38.3M+26.0% | $30.4M+56.9% | $19.4M |
| Current Liabilities | $186.0M+2.0% | $182.3M-17.9% | $222.1M-34.9% | $341.1M+64.5% | $207.4M-11.2% | $233.7M+251.0% | $66.6M-11.6% | $75.3M-1.4% | $76.4M+40.0% | $54.5M-2.3% | $55.8M+67.9% | $33.2M-10.5% | $37.2M+25.7% | $29.6M+59.9% | $18.5M |
| Long-Term Debt | $123.6M+0.5% | $123.0M+0.5% | $122.4M+0.5% | $121.8M-60.2% | $306.2M-15.8% | $363.6M+75.7% | $206.9M-19.1% | $255.8M-26.4% | $347.6M | $0 | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $451.9M-12.5% | $516.3M-24.8% | $686.3M+1.5% | $676.4M+38.3% | $489.2M+25.1% | $391.1M-5.7% | $414.9M+3.7% | $399.9M+3.2% | $387.4M+9.9% | $352.4M+34.0% | $262.9M+165.3% | $99.1M+14.3% | $86.7M+8.0% | $80.2M-13.8% | $93.0M |
| Retained Earnings | -$500.4M-37.6% | -$363.7M-206.9% | -$118.5M-161.2% | -$45.4M+73.4% | -$170.4M+19.8% | -$212.4M-86.6% | -$113.8M-21.5% | -$93.6M-35.5% | -$69.1M-15.3% | -$59.9M+50.6% | -$121.2M-53.9% | -$78.8M-9.8% | -$71.7M-21.6% | -$59.0M-75.2% | -$33.7M |
MXL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $16.5M | $19.6M+143.3% | -$45.3M-204.4% | $43.4M-88.8% | $388.7M+131.1% | $168.2M+128.6% | $73.6M-6.1% | $78.3M-23.7% | $102.7M+36.8% | $75.1M-36.0% | $117.3M+113.1% | $55.0M+349.9% | $12.2M-5.1% | $12.9M+70.9% | $7.5M+206.1% | -$7.1M |
| Capital Expenditures | $13.2M | $12.6M-28.7% | $17.7M+31.4% | $13.5M-67.4% | $41.3M+5.3% | $39.2M+213.7% | $12.5M+81.3% | $6.9M-12.0% | $7.8M+4.8% | $7.5M-12.3% | $8.5M+184.1% | $3.0M-66.0% | $8.8M+178.3% | $3.2M-37.4% | $5.1M+70.7% | $3.0M |
| Free Cash Flow | $3.3M | $7.0M+111.1% | -$63.0M-310.5% | $29.9M-91.4% | $347.5M+169.2% | $129.1M+111.2% | $61.1M-14.5% | $71.5M-24.7% | $94.9M+40.3% | $67.6M-37.9% | $108.8M+109.1% | $52.0M+1415.6% | $3.4M-64.7% | $9.7M+290.8% | $2.5M+124.7% | -$10.1M |
| Investing Cash Flow | -$17.8M | -$19.8M+15.6% | -$23.4M-47.1% | -$15.9M+82.6% | -$91.8M0.0% | -$91.8M+47.7% | -$175.3M-2413.8% | -$7.0M+10.9% | -$7.8M+98.2% | -$432.2M-326.6% | -$101.3M-816.1% | -$11.1M+36.7% | -$17.5M-83.1% | -$9.5M-127.6% | -$4.2M-138.7% | $10.8M |
| Financing Cash Flow | -$14.7M | -$18.7M-1550.9% | $1.3M+104.9% | -$26.4M+89.0% | -$240.4M-161.6% | -$91.9M-157.6% | $159.6M+399.1% | -$53.4M+43.1% | -$93.8M-127.0% | $347.0M+51894.2% | -$670K-116.7% | $4.0M+891.1% | -$506K-139.8% | $1.3M+113.3% | -$9.6M-450.4% | $2.7M |
| Share Buybacks | N/A | $20.0M | $0 | $0-100.0% | $31.5M+33.8% | $23.5M | $0 | $0 | $0-100.0% | $334K+11033.3% | $3K-97.0% | $101K | $0 | $0-100.0% | $12.1M | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
MXL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.8%+2.8pp | 54.0%-1.6pp | 55.6%-2.4pp | 58.0%+2.4pp | 55.6%+11.1pp | 44.5%-8.4pp | 52.9%-1.4pp | 54.2%+4.7pp | 49.5%-9.8pp | 59.3%+7.6pp | 51.7%-9.8pp | 61.6%+0.6pp | 61.0%-1.1pp | 62.1%-0.8pp | 62.9% |
| Operating Margin | -27.1%+34.8pp | -62.0%-56.4pp | -5.5%-21.6pp | 16.1%+8.8pp | 7.3%+28.4pp | -21.1%-14.2pp | -7.0%-2.0pp | -5.0%+0.2pp | -5.2%-21.4pp | 16.3%+30.8pp | -14.5%-7.9pp | -6.7%+3.7pp | -10.3%+3.1pp | -13.4%+7.7pp | -21.0% |
| Net Margin | -29.2%+38.8pp | -68.0%-57.5pp | -10.5%-21.7pp | 11.2%+6.5pp | 4.7%+25.3pp | -20.6%-14.3pp | -6.3%+0.5pp | -6.8%-4.6pp | -2.2%-18.0pp | 15.8%+29.9pp | -14.1%-8.8pp | -5.3%+5.3pp | -10.6%+2.9pp | -13.6%+17.1pp | -30.6% |
| Return on Equity | -30.3%+17.2pp | -47.5%-36.8pp | -10.7%-29.1pp | 18.5%+9.9pp | 8.6%+33.8pp | -25.2%-20.4pp | -4.8%+1.8pp | -6.6%-4.2pp | -2.4%-19.8pp | 17.4%+33.5pp | -16.1%-9.0pp | -7.1%+7.6pp | -14.7%+1.8pp | -16.5%+7.2pp | -23.7% |
| Return on Assets | -17.2%+11.2pp | -28.4%-21.6pp | -6.8%-17.4pp | 10.6%+6.6pp | 4.0%+13.6pp | -9.6%-6.8pp | -2.8%+0.7pp | -3.5%-2.4pp | -1.1%-15.6pp | 14.5%+27.1pp | -12.7%-7.5pp | -5.2%+5.0pp | -10.2%+1.8pp | -12.0%+7.6pp | -19.6% |
| Current Ratio | 1.34-0.4x | 1.77-0.4x | 2.20+0.5x | 1.65-0.3x | 1.95+0.4x | 1.55-1.2x | 2.73+0.3x | 2.46-0.2x | 2.64-1.3x | 3.90+0.5x | 3.40+0.4x | 3.04+0.5x | 2.52-0.8x | 3.31-1.8x | 5.14 |
| Debt-to-Equity | 0.270.0x | 0.24+0.1x | 0.180.0x | 0.18-0.4x | 0.63-0.3x | 0.93+0.4x | 0.50-0.1x | 0.64-0.3x | 0.90+0.9x | 0.00-0.3x | 0.27-0.1x | 0.37-0.1x | 0.44+0.1x | 0.38+0.2x | 0.21 |
| FCF Margin | 1.5%+19.0pp | -17.5%-21.8pp | 4.3%-26.7pp | 31.0%+16.6pp | 14.5%+1.7pp | 12.8%-9.8pp | 22.5%-2.1pp | 24.6%+8.6pp | 16.1%-12.0pp | 28.1%+10.7pp | 17.3%+14.8pp | 2.6%-5.5pp | 8.1%+5.6pp | 2.5%+16.6pp | -14.0% |
Similar Companies
Where Maxlinear Ranks
Frequently Asked Questions
What is Maxlinear's annual revenue?
Maxlinear (MXL) reported $467.6M in total revenue for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Maxlinear's revenue growing?
Maxlinear (MXL) revenue grew by 29.7% year-over-year, from $360.5M to $467.6M in fiscal year 2025.
Is Maxlinear profitable?
No, Maxlinear (MXL) reported a net income of -$136.7M in fiscal year 2025, with a net profit margin of -29.2%.
What is Maxlinear's EBITDA?
Maxlinear (MXL) had EBITDA of -$82.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Maxlinear have?
As of fiscal year 2025, Maxlinear (MXL) had $72.8M in cash and equivalents against $123.6M in long-term debt.
What is Maxlinear's gross margin?
Maxlinear (MXL) had a gross margin of 56.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Maxlinear's operating margin?
Maxlinear (MXL) had an operating margin of -27.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Maxlinear's net profit margin?
Maxlinear (MXL) had a net profit margin of -29.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Maxlinear's return on equity (ROE)?
Maxlinear (MXL) has a return on equity of -30.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Maxlinear's free cash flow?
Maxlinear (MXL) generated $7.0M in free cash flow during fiscal year 2025. This represents a 111.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Maxlinear's operating cash flow?
Maxlinear (MXL) generated $19.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Maxlinear's total assets?
Maxlinear (MXL) had $796.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Maxlinear's capital expenditures?
Maxlinear (MXL) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Maxlinear spend on research and development?
Maxlinear (MXL) invested $208.6M in research and development during fiscal year 2025.
What is Maxlinear's current ratio?
Maxlinear (MXL) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.
What is Maxlinear's debt-to-equity ratio?
Maxlinear (MXL) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Maxlinear's return on assets (ROA)?
Maxlinear (MXL) had a return on assets of -17.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Maxlinear's Altman Z-Score?
Maxlinear (MXL) has an Altman Z-Score of 10.75, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Maxlinear's Piotroski F-Score?
Maxlinear (MXL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Maxlinear's earnings high quality?
Maxlinear (MXL) reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Maxlinear cover its interest payments?
Maxlinear (MXL) reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Maxlinear?
Maxlinear (MXL) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.